Yes, it is complete or they wouldn't have PRed it. 5hey did the same for Rett. It also stated results will be ready in mid-2022...that means it is complete and will be ready in 1 year...once the last patient has been dose for a year.
The KEY to this press release is that top line results are expected by mid-2022. "If" that turns out to be the case, that would be amazingly fast! AVXL could easily be a double or triple in price by then.
You have a valid point. Two extra words. Two extra, expected, words. Why leave them out? "Enrollment complete"; That wasn't hard.
For the record, I think it is complete, but I think it is a slightly ambiguous PR. But nit-picking aside, excited to see the company enter the next phase of its mission.